PETALING JAYA: Optimax Holdings Bhd
is expected to be a beneficiary of the ageing population and rising medical insurance penetration in the country.
CGS-CIMB Research estimated that the eye specialist service provider would see a robust earnings per share growth at 14.7% of compounded annual growth rate from the financial year 2021 (FY21) to FY24, mainly driven by network expansion and improving revenue intensity.
The growth is expected to be driven by higher demand for cataract and refractive surgeries, improving revenue on the take-up of new-generation procedures and muted competition. It will also gain from the opening of new centres, and normalisation of effective tax rate.
“With its established track record, Optimax is poised to benefit from the rapidly ageing population and rising medical insurance penetration as we think cataract surgeries will form about 31% of FY22 forecast revenue ex-Covid-19 vaccination services.
...